These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24155843)

  • 41. Patient medication counselling in community pharmacy: evaluation of the quality and content.
    Showande SJ; Laniyan MW
    J Pharm Policy Pract; 2022 Dec; 15(1):103. PubMed ID: 36527122
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Community pharmacists' role in caring for people living with epilepsy: A scoping review.
    Bacci JL; Zaraa S; Stergachis A; Simic G; White HS
    Epilepsy Behav; 2021 Apr; 117():107850. PubMed ID: 33631435
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Public attitudes towards community pharmacy in Arabic speaking Middle Eastern countries: A systematic review.
    El Hajj MS; Mekkawi R; Elkaffash R; Saleh R; El Awaisi A; Wilbur K
    Res Social Adm Pharm; 2021 Aug; 17(8):1373-1395. PubMed ID: 33257161
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment and management of serotonin syndrome in a simulated patient study of Australian community pharmacies.
    Macfarlane B; Bergin J; Peterson GM
    Pharm Pract (Granada); 2016; 14(2):703. PubMed ID: 27382424
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gap between patient expectation and perception during pharmacist-patient communication at community pharmacy.
    Kim MG; Lee NE; Sohn HS
    Int J Clin Pharm; 2020 Apr; 42(2):677-684. PubMed ID: 32266556
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The quality of non-prescription medicine counselling in Finnish pharmacies - a simulated patient study.
    Alastalo N; Siitonen P; Jyrkkä J; Hämeen-Anttila K
    Explor Res Clin Soc Pharm; 2023 Sep; 11():100304. PubMed ID: 37521017
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Promoting weight management services in community pharmacy: perspectives of the pharmacy team in Scotland.
    Weidmann AE; MacLure K; Marshall S; Gray G; Stewart D
    Int J Clin Pharm; 2015 Aug; 37(4):599-606. PubMed ID: 25822039
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hospital pharmacists' and patients' views about what constitutes effective communication between pharmacists and patients.
    Chevalier BAM; Watson BM; Barras MA; Cottrell WN
    Int J Pharm Pract; 2018 Oct; 26(5):450-457. PubMed ID: 29210472
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An investigation of the determinants for community pharmacists' positive image and the needs for community pharmacists' services in Taiwan.
    Tseng KH; Chang EH; Ko Y
    Int J Health Plann Manage; 2019 Oct; 34(4):1354-1363. PubMed ID: 31025426
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Computerized Pharmacy Decision Support System (PDSS) for Headache Management: Observational Pilot Study.
    Perrot S; Trouvin AP; Clairaz-Mahiou B; Tempremant G; Martial F; Brément D; Cherkaoui A
    Interact J Med Res; 2022 Nov; 11(2):e35880. PubMed ID: 36427228
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Critical Role of Pharmacists in Caring for Alzheimer's Disease Patients.
    Alzubaidi H; Saidawi W; Hussein A; Hasan S
    J Alzheimers Dis; 2020; 73(3):1253-1264. PubMed ID: 31903993
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacists' knowledge and counselling on fall risk increasing drugs in a tertiary teaching hospital in Nigeria.
    Akande-Sholabi W; Ogundipe FS; Adisa R
    BMC Health Serv Res; 2020 Mar; 20(1):259. PubMed ID: 32228567
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Provision of smoking cessation services in Australian community pharmacies: a simulated patient study.
    Saba M; Diep J; Bittoun R; Saini B
    Int J Clin Pharm; 2014 Jun; 36(3):604-14. PubMed ID: 24718946
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stroke patients' support: evaluation of knowledge, practices and training needs of French community pharmacists.
    Khettar S; Viprey M; Haesebaert J; Jacquin-Courtois S; Luauté J; Mechtouff L; Derex L; Rode G; Dussart C; Janoly-Dumenil A
    Int J Clin Pharm; 2021 Aug; 43(4):980-989. PubMed ID: 33387187
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making.
    Paudyal V; Hansford D; Cunningham S; Stewart D
    Res Social Adm Pharm; 2014; 10(1):88-105. PubMed ID: 23665077
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacist views and pharmacy capacity to deliver professional services in the United Arab Emirates.
    Alzubaidi H; Saidawi W; Mc Namara K
    Int J Clin Pharm; 2018 Oct; 40(5):1106-1115. PubMed ID: 29926256
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Community pharmacists' attitudes, barriers, knowledge and counseling practice with regard to preconception, pregnancy and lactation.
    Ceulemans M; Liekens S; Van Calsteren K; Allegaert K; Foulon V
    Res Social Adm Pharm; 2020 Sep; 16(9):1192-1200. PubMed ID: 31864884
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of community pharmacists' recommendations to standardized patient scenarios.
    Rutter PM; Horsley E; Brown DT
    Ann Pharmacother; 2004 Jun; 38(6):1080-5. PubMed ID: 15113984
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Community pharmacists' perceptions of services that benefit older people in New Zealand.
    Tordoff J; Chang SY; Norris PT
    Int J Clin Pharm; 2012 Apr; 34(2):342-50. PubMed ID: 22328011
    [TBL] [Abstract][Full Text] [Related]  

  • 60. How to best manage time interaction with patients? Community pharmacist workload and service provision analysis.
    Gregório J; Cavaco AM; Lapão LV
    Res Social Adm Pharm; 2017; 13(1):133-147. PubMed ID: 26997136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.